Abstract. A VFA mixture solution containing acetate, propionate and butyrate (the molar ratio of acetate, propionate and n-butyrate = 61.7:24.3:14.0) was infused into the rumen at various rates (53.5, 107 and 214 ,umol kg-i mini) over 6 h to examine the effects on basal and growth hormone-releasing factor (GRF, 0.25 µg kg-i)-induced increase in secretion of GH, insulin, glucagon and somatostatin (SRIF) in five castrated male sheep. Intraruminal infusion of the VFA mixture into the 18-h-fasted animals at the rates of 53.5, 107 and 214 j mol kg-i min-1 finally raised the total intraruminal VFA concentration from 91.4 to 100.2 (P>0.05), 175.9 (P<0.05) and 234.5 (P<0.05) mmol 1-1, respectively. A preliminary experiment showed that an infusion rate of 107 jimol kg-i min-1 mimics the postprandial increase in ruminal VFA. The basal plasma GH concentrations (2 to 4 h after the start of VFA infusion) and the area under the profiles for GH release in response to the intravenous GRF injection, which was done 4 h after the start of VFA infusion, were significantly decreased by the VFA infusion rates of 107 and 214 µmol kg-1 min-1. Furthermore, the VFA infusion noticeably increased basal plasma concentrations of insulin, but it scarcely changed the basal levels of glucagon, SRIF and glucose. From these results we conclude that an increase in the ruminal VFA concentration, even within the physiological range, would suppress GH secretion from the ovine anterior pituitary, and that the postprandial rise in the ruminal VFA concentration may be one of the factors normally suppressing GH secretion in sheep. Although large quantities of volatile fatty acids (VFA) are produced from dietary carbohydrates by microbial fermentation in the rumen, to meet a large proportion of the requirements for energy and cause an increase in the secretion of metabolic hormones such as insulin and glucagon [1,7], little attention has been paid to GH secretion following feeding in ruminants.The results that have been published are conflicting [1,[8][9][10]. In our previous study [11], intravenous infusion of propionate or butyrate at rates of 3,10 and 30 pmol kg-i min-1,